On-Demand CE Available Now!

We're so excited to share the 2020 Annual Convention CE programs with you on-demand! Free for Annual Convention Attendees!
Check them out!

Call for Speakers

Call for Speakers

Interested in speaking or have ideas for topics? Let us know! The next event is Spring Clinical in February, 2021

2021 Spring Clinical

February 2021

This 1.5 day seminar provides approximately eleven (11) hours of continuing education for pharmacy professionals focusing on clinical topics pertinent to institutional and ambulatory care settings. Stay tuned for more details!

2021 Pharmacy Day at the Capitol

2021 Pharmacy Day at the Capitol

This event (February 4, 2021) offers pharmacy professionals the opportunity to connect with each other over issues important to the pharmacy profession while bringing those issues to the attention of our state legislators.  Our joined voices can make a difference!

Arizona Pharmacy Podcast Network

NOW AVAILABLE!!

AzPA presents an innovative podcast intended for pharmacists and pharmacy technicians to obtain continuing education credit. The podcast also provides current health information and hot topics in the evolving world of pharmacy.

AzPA Pain Management Certificate Program

Offered Virtually December 12, 2020!

Innovative and interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.

Education

Learn with us

Advocacy

Discover your voice

Connection

Get involved! Serve on a team

RSS AzPA Pharmacy Flash

  • FDA approves first intratumoral injection to treat non-metastatic mast cell tumors in dogs
    The U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog’s skin (subcutaneous), in particular areas of a dog’s leg. Stelfonta is injected directly into the MCT (intratumoral injection). Stelfonta […]
  • PD-L1 IHC 22C3 pharmDx gets FDA approval as companion diagnostic for pembrolizumab in breast cancer
    The FDA has approved the PD-L1 IHC 22C3 pharmDx to aid in the identification of patients with triple-negative breast cancer (TNBC) who are eligible to receive the PD-1 inhibitor pembrolizumab (Keytruda), according to an announcement from Agilent Technologies, Inc. Previously, the test had also been approved to identify PD-L1 positivity in patients with non–small cell […]
  • Pharmacy groups welcome pharmacists elected to U.S. Congress
    Pharmacy groups welcomed incoming members of Congress — including three who are pharmacists — after the United States election. They also stressed pharmacy-centered issues for Congress to focus on when they reconvene in January. “We’re excited Rep. Buddy Carter (R-GA) is being joined in Congress by another pharmacist, Diana Harshbarger of Tennessee, and pharmacy owner […]

Upcoming Events

Upcoming Events

AzPA Immunization Training Program

12/13/2020

Virtual Webinar

ENDORSED PARTNER OF AzPA

ENDORSED PARTNER OF AzPA

ENDORSED PARTNER OF AzPA

ENDORSED PARTNER OF AzPA